"Title","Dosage of interferon-γ","Has method","has research problem","Has result","median mHLA-DR expression in ICU patients at admission to ICU","median mHLA-DR expression in ICU patients at day 5","Number of patients studied","same as","Study location","Study population","Study type"
"Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome","1x Injection of 100 mcg subcutaneous",", Interferon-γ therapy in COVID-19","Immunosuppression Syndrome in COVID-19","Expression of Monocytic Human Leukocyte Antigen Receptor","","","1","https://sws.geonames.org/2921044/",", Germany","COVID-19-positive patients","Case report"
"Reduced monocytic human leukocyte antigen-DR expression indicates immunosuppression in critically ill COVID-19 patients","","","Immunosuppression Syndrome in COVID-19",", Expression of Monocytic Human Leukocyte Antigen Receptor","9280 antibodies/cell","7334 antibodies/cell, 9672 antibodies/cell","16","https://sws.geonames.org/2658434/","Switzerland","COVID-19-positive patients",""
"Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome","","","Immunosuppression Syndrome in COVID-19","Expression of Monocytic Human Leukocyte Antigen Receptor","11125 antibodies/cell","10838 antibodies/cell, 6914 antibodies/cell, 7347 antibodies/cell, 9121 antibodies/cell","64","","France","Critically ill COVID-19 patients","prospective  observational  clinical  study"
"Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients","","","immunological parameters in critically ill COVID-19 patients","Expression of Monocytic Human Leukocyte Antigen Receptor","11884 antibodies/cell","10012 antibodies/cell, 8436 antibodies/cell","30","","France","",""
"Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: A hypothesis","Injection of 100 mcg subcutaneous once daily for 5 days",", Interferon-γ therapy in COVID-19","recurrent ventilator-acquired pneumonia in patients with COVID-19","Expression of Monocytic Human Leukocyte Antigen Receptor","","","6","","France","Critically ill COVID-19 patients",""
"Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series","100mcg per subcutaneous injection, repeated at least 3days with a maximum duration of 5 days","Interferon-γ therapy in sepsis","sepsis induced immunosuppression","Expression of Monocytic Human Leukocyte Antigen Receptor","","","18 adults and 2 pediatric","","France and the Netherlands",", Adults and pediatric sepsis patients","Case series"